UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.522

Sortiert nach

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita

Blood, 2007-09, Vol.110 (5), p.1439-1447

2007

Link zum Volltext

Verfügbarkeit prüfen

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique

Blood, 2001-02, Vol.97 (3), p.822-825

2001

Link zum Volltext

Verfügbarkeit prüfen

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology

Blood, 2018-05, Vol.131 (18), p.2060-2064

2018

Link zum Volltext

Verfügbarkeit prüfen

Trisomy 12 in Chronic Lymphocytic Leukemia Detected by Fluorescence in Situ Hybridization: Analysis by Stage, Immunophenotype, and Morphology

Blood, 1993-07, Vol.82 (2), p.571-575

1993

Link zum Volltext

Verfügbarkeit prüfen

Del(1p32): prime time in (ultra) high-risk myeloma

Blood, 2023-03, Vol.141 (11), p.1241-1243

Khot, Amit

2023

Link zum Volltext

Verfügbarkeit prüfen

The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH

Blood, 2019-10, Vol.134 (18), p.1528-1532

2019

Link zum Volltext

Verfügbarkeit prüfen

The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

Blood, 2014-03, Vol.123 (11), p.1637-1646

2014

Link zum Volltext

Verfügbarkeit prüfen

Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements

Blood, 2017-01, Vol.129 (3), p.280-288

2017

Link zum Volltext

Verfügbarkeit prüfen

Fluorescence in Situ Hybridization Analysis of t(3; 12)(q26;p13): A Recurring Chromosomal Abnormality Involving the TEL Gene (ETV6) in Myelodysplastic Syndromes

Blood, 1996-07, Vol.88 (2), p.682-689

1996

Link zum Volltext

Verfügbarkeit prüfen

Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice

Blood, 2024-03, Vol.143 (13), p.1293

2024

Link zum Volltext

Verfügbarkeit prüfen

PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype

Blood, 2019-05, Vol.133 (21), p.2279-2290

2019

Link zum Volltext

Verfügbarkeit prüfen

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

Blood, 2005-01, Vol.105 (1), p.358-360

2005

Link zum Volltext

Verfügbarkeit prüfen

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

Blood, 2010-10, Vol.116 (15), p.e56-e65

2010

Link zum Volltext

Verfügbarkeit prüfen

Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis

Blood, 2016-04, Vol.127 (14), p.1752-1760

2016

Link zum Volltext

Verfügbarkeit prüfen

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System

Blood, 2015-10, Vol.126 (17), p.1996-2004

2015

Link zum Volltext

Verfügbarkeit prüfen

Detection of the t(2; 5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization

Blood, 1997-03, Vol.89 (5), p.1678-1685

1997

Link zum Volltext

Verfügbarkeit prüfen

Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis

Blood, 2017-01, Vol.129 (4), p.420-423

2017

Link zum Volltext

Verfügbarkeit prüfen

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

Blood, 2012-03, Vol.119 (9), p.2100-2105

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.522

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Nature - Connect here FIRST to enable access

SpracheJapanisch

Zeitschrift / SerieBlood

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.522)
Mit Volltextzugriff
(1.518)

Publikationsform

Artikel
(1.522)

Sprache

Englisch
(1.522)

Erscheinungsjahr

n.n

Thema

Humans
(405)
Hematology
(375)
Life Sciences & Biomedicine
(370)
Science & Technology
(370)
Biological And Medical Sciences
(291)
In Situ Hybridization, Fluorescence
(285)
Medical Sciences
(281)
Male
(229)
Hematologic And Hematopoietic Diseases
(215)
Female
(212)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(203)
Middle Aged
(178)
Adult
(170)
Aged
(148)
Translocation, Genetic
(125)
Prognosis
(85)
Chromosome Aberrations
(72)
Aged, 80 And Over
(70)
Molecular Sequence Data
(52)
Adolescent
(50)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Zeitschrift / Serie

56th Annual Meeting Of The American Society Of Hematology,san Francisco, United States,2014-12-06 - 2014-12-09
(1)

Menü

Weitere Dienste

Einstellungen

Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology

Trisomy 12 in Chronic Lymphocytic Leukemia Detected by Fluorescence in Situ Hybridization: Analysis by Stage, Immunophenotype, and Morphology

Del(1p32): prime time in (ultra) high-risk myeloma

The double-hit signature identifies double-hit diffuse large B-cell lymphoma with genetic events cryptic to FISH

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes

The genomic landscape of Waldenström macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor

Approach to the diagnosis and treatment of high-grade B-cell lymphomas with MYC and BCL2 and/or BCL6 rearrangements

CD34+CD19-CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

Fluorescence in Situ Hybridization Analysis of t(3; 12)(q26;p13): A Recurring Chromosomal Abnormality Involving the TEL Gene (ETV6) in Myelodysplastic Syndromes

Developmental trajectories and cooperating genomic events define molecular subtypes of BCR::ABL1-positive ALL

Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population

Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice

PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype

p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation

A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value

Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging System

Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness

Detection of the t(2; 5)(p23;q35) and NPM-ALK fusion in non-Hodgkin's lymphoma by two-color fluorescence in situ hybridization

Near-haploid and low-hypodiploid acute lymphoblastic leukemia: two distinct subtypes with consistently poor prognosis

Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

Aktive Filter

Suchergebnisse filtern